We are live on ! Find out more
HOOK

HOOKIPA Pharma
HOOK

Delisted

HOOK was delisted on the 7th of August, 2025.

Back to rankings

38 hedge funds and large institutions have $10.7M invested in HOOKIPA Pharma in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more call options, than puts

Call options by funds: $48K | Put options by funds: $6K

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

18.29% more ownership

Funds ownership: 37.06% → 55.35% (+18%)

9% more funds holding

Funds holding: 35 → 38 (+3)

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

47% less capital invested

Capital invested by funds: $20.2M → $10.7M (-$9.47M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
38
Holders Change
+3
Holders Change %
+8.57%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
6
Reduced
9
Closed
5
Calls
$48K
Puts
$6K
Net Calls
+$42K
Net Calls Change
+$755K

Top Buyers

Rank Fund Capital Flow
1
Squarepoint
Squarepoint
New York
+$161K
2
EGM
Engineers Gate Manager
New York
+$73.4K
3
Citadel Advisors
Citadel Advisors
Florida
+$66.6K
4
Morgan Stanley
Morgan Stanley
New York
+$55.4K
5
Millennium Management
Millennium Management
New York
+$47.4K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$566K
2
KCM
Knoll Capital Management
Florida
-$164K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$75K
4
GCP
GSA Capital Partners
United Kingdom
-$71K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$13.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$17.8K +$18.2K +5,868 +196%
TRCT
27
Tower Research Capital (TRC)
New York
$6.92K +$7.32K +2,367 +220%
JP Morgan Chase
28
JP Morgan Chase
New York
$1.78K – – –
Bank of America
29
Bank of America
North Carolina
$949 -$291 -94 -17%
Group One Trading
30
Group One Trading
Illinois
$261 -$11K -3,549 -96%
PA
31
Parallel Advisors
California
$70 – – –
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$66 – – –
FDCDDQ
33
Federation des caisses Desjardins du Quebec
Quebec, Canada
$66 – – –
SS
34
SBI Securities
Japan
$26 +$40 +13 New
BF
35
BOK Financial
Oklahoma
$17 – – –
Citigroup
36
Citigroup
New York
$14 – – –
TC
37
Truvestments Capital
Florida
$4 – – –
GCP
38
GSA Capital Partners
United Kingdom
– -$71K -16,609 Closed
NS
39
NBC Securities
Alabama
– -$2K -600 Closed
Wells Fargo
40
Wells Fargo
California
– -$142 -33 Closed
Northwestern Mutual Wealth Management
41
Northwestern Mutual Wealth Management
Wisconsin
– -$34 -8 Closed
Simplex Trading
42
Simplex Trading
Illinois
– +$374 +121 New
1
2

HOOK Hedge Fund Activity: Q4 2024 in Review

38 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q4 2024, worth a combined $10.7M — down 47% from $20.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new HOOK positions and 5 closed out — a net gain of 3 holders — while 6 added to existing stakes and 9 trimmed.

The largest buyer was Squarepoint, opening a new position worth an estimated $161K. The largest seller was EcoR1 Capital, cutting an estimated $566K.

  • 38 institutional investors held HOOKIPA Pharma (HOOK) as of Q4 2024, up from 35 in Q3 2024.
  • Funds reported $10.7M of HOOKIPA Pharma stock for Q4 2024, down 47% quarter-over-quarter.
  • 8 funds opened new HOOKIPA Pharma positions in Q4 2024 and 5 closed out, a net change of +3 holders.
  • The largest HOOKIPA Pharma buyer in Q4 2024 was Squarepoint, an estimated $161K added.
  • The largest HOOKIPA Pharma seller in Q4 2024 was EcoR1 Capital, an estimated $566K sold.

Based on aggregated 13F filings for Q4 2024.